News

Read more about the latest developments at Curate Biosciences

Curate Biosciences and City of Hope Evaluate Innovative Cell Separation for HIV CAR-T Cell Therapy Production

GPB Scientific becomes Curate Biosciences, targets 50% reduction in autologous cell therapy costs

GPB Scientific announces go-to-market kickoff under new brand: Curate Biosciences

GPB Scientific Accelerates Cell Therapy Manufacturing with Key Hires

GPB Scientific Increases Second Tranche of Venture-backed Growth Financing from $10 to $ 18 million to Support Commercialization of Curate® Cell Processing System

GPB Scientific Announces $25.5 Million Financing from Vensana Capital and Amgen Ventures

GPB Scientific Awarded Phase II of $2.2M NIH Grant to Complete Development of Microfluidic CAR-T Cell Processing Device